CDSCO, Maharashtra FDA assures medicine availability amid AIOCD nationwide strike on May 20: Shardul Nautiyal, Mumbai Tuesday, May 19, 2026, 15:50 Hrs [IST] The Central Drugs Stan ...
Pondicherry DC dept issues safety advisory ahead of nationwide pharma bandh on May 20: Our Bureau, Chennai Tuesday, May 19, 2026, 15:30 Hrs [IST] The drugs control department in P ...
Parexel launches ParexelAI delivering AI innovation to accelerate clinical development: Our Bureau, Bengaluru Tuesday, May 19, 2026, 15:45 Hrs [IST] Parexel, a leading global clin ...
Telangana DCA cracks down on pharmacies, 144 medical shops issued show cause notices over regulatory violations: Our Bureau, Chennai Tuesday, May 19, 2026, 14:15 Hrs [IST] In a ma ...
MedGenome makes majority investment into Siddhi Diagnostics & Research Centre, strengthening its footprint into Mumbai: Our Bureau, Bengaluru Tuesday, May 19, 2026, 13:45 Hrs [IST ...
Lab India & PharmaCore India records strong industry participation: Our Bureau, Mumbai Tuesday, May 19, 2026, 14:00 Hrs [IST] Drawing participation from across India and ...
TTCDA mobilizes regulators for May 20 pharmacy bandh, warning of online drug risks: Our Bureau, Chennai Tuesday, May 19, 2026, 13:30 Hrs [IST] In a strategic move to intensify pre ...
Boehringer Ingelheim’s Jascayd approved in Japan to treat idiopathic pulmonary fibrosis & progressive pulmonary fibrosis: Ingelheim, Germany Tuesday, May 19, 2026, 13:00 Hrs [IS ...
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...
Merck announces TroFuse-005 trial of sacituzumab tirumotecan meets primary endpoints of OS and PFS in certain patients with advanced or recurrent endometrial cancer: Rahway, New J ...
Chugai Pharma’s Alecensa receives the Japanese approval for ALK fusion gene-positive solid tumours across adult and paediatric patients: Tokyo Tuesday, May 19, 2026, 10:00 Hrs [ ...
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to growth-stage life sciences and healthcare businesses, has made an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results